Now Is The Time To Build A Position In Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) has a beta value of 1.28 and has seen 2.47 million shares traded in the last trading session. The company, currently
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) has a beta value of 1.28 and has seen 2.47 million shares traded in the last trading session. The company, currently
In the last trading session, 1.4 million shares of the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) were traded, and its beta was 1.27. Most recently the company’s
In recent trading session today, 0.33 million shares of the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) have been traded, and its beta is 1.27. Most recently the
In the latest trading session, 0.88 million Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) shares changed hands as the company’s beta touched 1.29. With the company’s most recent
In last trading session, Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) saw 2.81 million shares changing hands with its beta currently measuring 1.29. Company’s recent per share price
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) has a beta value of 1.29 and has seen 2.75 million shares traded in the last trading session. The company, currently
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) has a beta value of 1.29 and has seen 0.78 million shares traded in the recent trading session. The company, currently
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.